Case number 1:23-cv-01015
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 24, 2024 | 56 | NOTICE OF SERVICE of (1) Heron's Second Set of Interrogatories (Nos. 3-16); and (2) Heron's Second Set of Requests for the Production of Documents and Things (Nos. 51-52) filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 06/24/2024) (3) |
| May 13, 2024 | 55 | STIPULATION to Extend Time re 49 (The deadline has passed therefore this entry is just for the record). Signed by Judge William C. Bryson on 5/13/2024. (nmg) (Entered: 05/13/2024) (1) |
| May 10, 2024 | 54 | NOTICE OF SERVICE of (1) Heron's Objections and Responses to Mylan Pharmaceutical Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-8); and (2) Heron's Objections and Responses to Mylan Pharmaceutical Inc.'s Second Set of Requests for Production to Plaintiff (Nos. 67-96) filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 05/10/2024) (3) |
| May 2, 2024 | 53 | CLAIM Construction Chart by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 05/02/2024) (3) |
| Apr 18, 2024 | 52 | NOTICE OF SERVICE of Plaintiff Heron Therapeutics Inc.'s Initial Infringement Contentions Against Defendant Mylan Pharmaceuticals, Inc. filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 04/18/2024) (3) |
| Apr 10, 2024 | 51 | NOTICE OF SERVICE of Defendant Mylan Pharmaceutical Inc.'s Second Set of Requests for Production to Plaintiff (Nos. 67-96), and Defendant Mylan Pharmaceutical Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-8) filed by Mylan Pharmaceuticals Inc..(Moshos, Andrew) (Entered: 04/10/2024) (2) |
| Mar 28, 2024 | 50 | NOTICE OF SERVICE of Mylan Pharmaceutical Inc.'s Invalidity Contentions filed by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/28/2024) (2) |
| Mar 25, 2024 | 49 | STIPULATION TO EXTEND TIME for Mylan Pharmaceuticals Inc. to serve its invalidity contentions to March 28, 2024 - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/25/2024) (1) |
| Mar 4, 2024 | 48 | NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses to Heron's First Set of Interrogatories (Nos. 1-2), and Mylan Pharmaceuticals Inc.'s Responses to Heron's First Set of Production of Documents and Things (Nos. 1-50) filed by Mylan Pharmaceuticals Inc..(Moshos, Andrew) (Entered: 03/04/2024) (2) |
| Feb 23, 2024 | 47 | ANSWER to 39 Answer to Complaint, Counterclaim by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 02/23/2024) (16) |
| Feb 21, 2024 | 46 | NOTICE OF SERVICE of Heron's Objections and Responses to Mylan Pharmaceutical Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-66) filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 02/21/2024) (3) |
| Feb 16, 2024 | 45 | ANSWER to 33 Answer to Amended Complaint, Counterclaim by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 02/16/2024) (17) |
| Feb 16, 2024 | 44 | STIPULATED PROTECTIVE ORDER Signed by Judge William C. Bryson on 2/16/2024. (mpb) (Entered: 02/16/2024) (27) |
| Feb 16, 2024 | 43 | Joint PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 02/16/2024) (27) |
| Feb 9, 2024 | 42 | NOTICE OF SERVICE of (1) Plaintiff's Asserted Claims Disclosure; (2) Plaintiff's Rule 26(a)(1) Initial Disclosures; and (3) Plaintiff's Initial Paragraph 3 Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 41 | NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals, Inc.'s Paragraph 3 Initial Disclosures and Defendant Mylan Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Rule 26(A)(1) filed by Mylan Pharmaceuticals Inc..(Moshos, Andrew) (Entered: 02/09/2024) (2) |
| Feb 2, 2024 | 40 | NOTICE OF SERVICE of (1) Heron's First Set of Interrogatories (Nos. 1-2); and (2) Heron's First Set of Requests for the Production of Documents and Things (Nos. 1-50) filed by Heron Therapeutics, Inc..(Tigan, Jeremy) (Entered: 02/02/2024) (3) |
| Feb 2, 2024 | 39 | ANSWER to Complaint (in 24-43 action),Separate Defenses, and, COUNTERCLAIM against Heron Therapeutics, Inc. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/02/2024) (30) |
| Feb 2, 2024 | 38 | SCHEDULING ORDER: Joinder of Parties due by 8/16/2024. Discovery due by 9/30/2024. Opening Expert Reports due by 10/28/2024. Rebuttal Expert Reports due by 12/2/2024. Reply Expert Reports due by 1/6/2025. Dispositive Motions due by 2/24/2025. Claim Construction Opening Brief due by 5/22/2024. Claim Construction Answering Brief due by 6/14/2024. Claim Construction Reply Brief due by 7/12/2024. Claim Construction Surreply Brief due by 7/26/2024. A 5 Day Bench Trial is set for 5/19/2025 - 5/23/2025 at 08:30 AM in To Be Determined before Judge William C. Bryson. Signed by Judge William C. Bryson on 2/2/2024 (SEE ORDER FOR FURTHER DETAILS AND DATES) (apk) (Entered: 02/02/2024) (7) |
| Feb 1, 2024 | 37 | Joint PROPOSED ORDER -- Proposed Consolidated Scheduling Order -- by Heron Therapeutics, Inc.. (Attachments: # 1 Letter to The Honorable William C. Bryson)(Tigan, Jeremy) (Entered: 02/01/2024) (0) |
| Jan 26, 2024 | 36 | STIPULATION AND ORDER consolidating cases. Signed by Judge William C. Bryson on 1/26/2024. Associated Cases: 1:23-cv-01015-WCB, 1:24-cv-00043-WCB(gva) (Entered: 01/26/2024) (2) |
| Jan 26, 2024 | 35 | Joint Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Consolidation - re (12 in 1:24-cv-00043-WCB, 34 in 1:23-cv-01015-WCB) Stipulation. (Tigan, Jeremy) (Entered: 01/26/2024) (2) |
| Jan 26, 2024 | 34 | STIPULATION and [Proposed] Order to Consolidate and Extend Time by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 01/26/2024) (2) |
| Jan 26, 2024 | 33 | ANSWER to Amended Complaint, re: 30 Amended Complaint , COUNTERCLAIM to Amended Complaint against Heron Therapeutics, Inc. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/26/2024) (30) |
| Jan 24, 2024 | 32 | NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s First Set of Requests for Production to Plaintiff (Nos. 1-66) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 01/24/2024) (2) |
| Jan 23, 2024 | N/A | Pro Hac Vice Attorney Mark Russell Sperling, Christopher P. Hill, Isaac S. Ashkenazi, and Bruce M. Wexler for Heron Therapeutics, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 01/23/2024) (0) |
| Jan 20, 2024 | 31 | ORDER: Heron is ordered to produce the following materials from the Fresenius litigation by January 26, 2024: invalidity contentions, any response thereto by Plaintiff, opening and reply expert reports regarding invalidity, and response reports served by Plaintiff. Both parties are directed to address whether Case No. 24-43 should be consolidated with this case by January 26, 2024. Signed by Judge William C. Bryson on 1/20/2024. (gva) (Entered: 01/20/2024) (6) |
| Jan 12, 2024 | 30 | Amended Complaint* (1) |
| Jan 11, 2024 | 27 | Unopposed MOTION for Leave to File Amended Complaint - filed by Heron Therapeutics, Inc.. (Attachments: # 1 Exhibit 1 - Amended Complaint, # 2 Exhibits A-J to Amended Complaint, # 3 Exhibit 2 - Redline)(Tigan, Jeremy) (Entered: 01/11/2024) (0) |
| Jan 11, 2024 | 28 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,561,229 B2; 9,808,465 B2; 9,974,742 B2; 9,974,793 B2 ; 9,974,794 B2; 10,500,208 B2 ; 10,624,850 B2; 10,953,018 B2; 11,173,118 B2; 11,744,800 B2 (Amended). (Tigan, Jeremy) (Entered: 01/11/2024) (2) |
| Jan 11, 2024 | 29 | Heron's unopposed Motion for Leave to File an Amended Complaint, Dkt. No. 27, is GRANTED. Signed by Judge William C. Bryson on 1/11/2024. (gva) (Entered: 01/11/2024) (0) |
| Jan 10, 2024 | 26 | Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Heron Therapeutics, Inc.'s Response to Mylan Pharmaceutical Inc.'s January 5, 2024 Letter - re 23 Letter. (Tigan, Jeremy) (Entered: 01/10/2024) (3) |
| Jan 10, 2024 | 25 | Letter to The Honorable William C. Bryson from Andrew M. Moshos regarding Discovery Dispute Reply Letter Brief - re 24 Letter. (Moshos, Andrew) (Entered: 01/10/2024) (5) |
| Jan 5, 2024 | 24 | Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Heron's Response to Mylan's Proposal - re Settlement Conference, Scheduling Conference. (Tigan, Jeremy) (Entered: 01/05/2024) (3) |
| Jan 5, 2024 | 23 | Letter to The Honorable William C. Bryson from Andrew M. Moshos regarding opening discovery dispute letter brief re production of invalidity materials. (Attachments: # 1 Exhibit 1)(Moshos, Andrew) (Entered: 01/05/2024) (0) |
| Jan 5, 2024 | 22 | STIPULATION AND ORDER regarding D.I. 21 . The deadline for Plaintiff Heron Therapeutics, Inc. to answer, move, or otherwise respond to Defendant Mylan Pharmaceuticals Inc.'s counterclaims (D.I. 14 ) is extended to January 12, 2024. (Notice of Compliance deadline set for 1/12/2024) Signed by Judge William C. Bryson on 1/5/2024. (apk) (Entered: 01/05/2024) (1) |
| Jan 5, 2024 | 21 | STIPULATION TO EXTEND TIME for Plaintiff Heron Therapeutics, Inc. to answer, move, or otherwise respond to Defendant Mylan Pharmaceuticals Inc.'s counterclaims (D.I. 14) to January 12, 2024 - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 01/05/2024) (1) |
| Jan 3, 2024 | N/A | Minute Entry for proceedings held before Judge William C. Bryson - Scheduling Conference held on 12/18/2023. Scheduling order delayed pending briefing on whether defendant must produce invalidity contentions from related case. (gva) (Entered: 01/03/2024) (0) |
| Dec 26, 2023 | 20 | STIPULATION AND ORDER regarding D.I. 19 STIPULATION TO EXTEND TIME for Plaintiff Heron Therapeutics, Inc. to answer, move, or otherwise respond to Defendant Mylan Pharmaceuticals Inc.'s counterclaims (D.I. 14 ) to January 5, 2024 (Notice of Compliance deadline set for 1/5/2024) Signed by Judge William C. Bryson on 12/26/2023. (apk) (Entered: 12/26/2023) (1) |
| Dec 26, 2023 | 19 | STIPULATION TO EXTEND TIME for Plaintiff Heron Therapeutics, Inc. to answer, move, or otherwise respond to Defendant Mylan Pharmaceuticals Inc.'s counterclaims (D.I. 14) to January 5, 2024 - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 12/26/2023) (1) |
| Dec 22, 2023 | 18 | NOTICE requesting Clerk to remove Elham Firouzi Steiner as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 12/22/2023) (1) |
| Dec 15, 2023 | 17 | NOTICE of Appearance by Anthony David Raucci on behalf of Heron Therapeutics, Inc. (Raucci, Anthony) (Entered: 12/15/2023) (2) |
| Dec 12, 2023 | 16 | Joint PROPOSED ORDER -- [Joint Proposed] Scheduling Order -- by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 12/12/2023) (8) |
| Dec 4, 2023 | 15 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 12/04/2023) (2) |
| Dec 4, 2023 | 14 | ANSWER to 1 Complaint ,Separate Defenses, and, COUNTERCLAIM against Heron Therapeutics, Inc. by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 12/04/2023) (30) |
| Nov 30, 2023 | N/A | Pro Hac Vice Attorneys Elham F. Steiner, Wendy L. Devine, Tung-On Kong, and Jody Karol for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 11/30/2023) (0) |
| Nov 28, 2023 | 13 | ORDER granting D.I. 12 Motion to Appear Pro Hac Vice of T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Jody Karol. Signed by Judge William C. Bryson on 11/28/2023. (apk) (Entered: 11/28/2023) (5) |
| Nov 28, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Jody Karol of Wilson Sonsini Goodrich & Rosati P.C. - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/28/2023) (5) |
| Nov 17, 2023 | 11 | ORAL ORDER: At the request of the parties, the scheduling conference set for November 28, 2023, has been canceled and will be rescheduled for December 18, 2023, at 10 a.m. Eastern Time. The deadline for filing a joint status report regarding the scheduling order is extended to December 12, 2023. Signed by Judge William C. Bryson on 11/17/2023. (gva) (Entered: 11/17/2023) (0) |
| Nov 8, 2023 | 10 | ORDER: A Telephonic Scheduling Conference is set for 11/28/2023 at 10:00 AM before Judge William C. Bryson. Joint Status Report due by 11/22/2023. (See Order for further details and deadlines). Signed by Judge William C. Bryson on 11/8/2023. (rlr) (Entered: 11/09/2023) (9) |
| Oct 19, 2023 | 9 | ORDER granting D.I. 8 Motion to Appear Pro Hac Vice of Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling. Signed by Judge William C. Bryson on 10/19/2023. (apk) (Entered: 10/19/2023) (6) |
| Oct 5, 2023 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 10/05/2023) (6) |
| Oct 4, 2023 | 7 | WAIVER OF SERVICE returned executed by Heron Therapeutics, Inc.: For Mylan Pharmaceuticals Inc. waiver sent on 10/3/2023, answer due 12/4/2023. (Tigan, Jeremy) (Entered: 10/04/2023) (1) |
| Sep 20, 2023 | N/A | Case Assigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit (due to related case). Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb) (Entered: 09/20/2023) (0) |
| Sep 15, 2023 | 6 | Summons Issued as to Mylan Pharmaceuticals Inc. on 9/15/2023. (vfm) (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Heron Therapeutics, Inc.. (vfm) (Entered: 09/15/2023) (1) |
| Sep 15, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,561,229 B2 ;9,808,465 B2 ;9,974,742 B2 ;9,974,793 B2 ;9,974,794 B2. (vfm) (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/04/2023. Date of Expiration of Patent: 09/18/2035.Thirty Month Stay Deadline: 2/4/2026. (vfm) (Entered: 09/15/2023) (1) |
| Sep 15, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 09/15/2023) (3) |
| Sep 15, 2023 | 1 | Complaint* (1) |
